Aster DM Healthcare has received No Objection letters from both the BSE and National Stock Exchange of India for its proposed merger with Quality Care India Limited. The merger is subject to regulatory and shareholder approvals. This strategic move aims to consolidate operations and enhance efficiency within the healthcare group. The company has posted the relevant documents and details on its website.
Merger Cleared by Exchanges
Aster DM Healthcare has received significant approvals for its proposed merger. The BSE Limited and the National Stock Exchange of India Limited have both issued No Objection letters concerning the scheme to merge Quality Care India Limited with Aster DM Healthcare. The approvals, dated October 06, 2025, mark a key step forward in the merger process.
Details of the Scheme
The proposed merger of Quality Care India Limited, the “Transferor Company”, with Aster DM Healthcare aims to consolidate the businesses of both entities. This will also affect the shareholders and creditors under sections 230-232 of the Companies Act, 2013. The merger remains subject to other statutory and regulatory approvals, as well as the approval of the respective shareholders and creditors involved.
Key Conditions and Disclosures
The exchanges have stipulated certain conditions that must be met. These include full disclosure of ongoing legal proceedings, ensuring all liabilities of the Transferor Company are transferred to the Transferee Company, and providing detailed information to shareholders. Compliance with SEBI circulars is also mandatory. The company has also been advised to make the details of the proposed merger prominently in the notice sent to the shareholders.
Shareholding Impact
A key disclosure requirement relates to the shareholding pattern of Promoter/Promoter Group and Public shareholders before and after implementation of the scheme. This will allow shareholders to assess the impact of the merger on their holdings and voting rights. Investors are advised to carefully review all related documents before making decisions.
Financial and Operational Impacts
Aster DM Healthcare has also been instructed to disclose the financial and operational impacts of the scheme. This includes providing details about the value of assets and liabilities being transferred, the basis of valuation, and the impact on the revenue-generating capacity of the Transferee Company. Up-to-date financials must be made available on the company’s website.
Source: BSE
